Job Description Summary

BD is seeking a transformative and execution focused leader to serve as Vice President of R&D for its $2B+ Advanced Access Devices (AAD) and Peripheral Intravenous Catheter (PIVC) portfolio. This global role will lead global R&D teams driving innovation, executional excellence, and customer-centric product development to improve patient outcomes worldwide.

This role reports directly to the Vice President of R&D for Medication Delivery Solutions (MDS) and is a key member of the MDS R&D Leadership Team, contributing to strategic decision-making and cross-platform innovation initiatives. This role will partner with Business Unit and Functional Leaders to ensure seamless integration of AAD and PIVC technologies into MDS. The ideal candidate will be both a strategic thinker and hands-on leader, capable of inspiring teams, delivering results, and building a high-performing, future-ready organization.

Job Description

We are the makers of possible

BD is one of the largest global medical technology companies in the world. Advancing the world of health™ is our Purpose, and it’s no small feat. It takes the imagination and passion of all of us—from design and engineering to the manufacturing and marketing of our billions of MedTech products per year—to look at the impossible and find transformative solutions that turn dreams into possibilities.

We believe that the human element, across our global teams, is what allows us to continually evolve. Join us and discover an environment in which you’ll be supported to learn, grow and become your best self. Become a maker of possible with us.

Opportunity: VP R&D Advanced Access Devices (AAD) and Peripheral Intravenous Catheters (PIVC)

Segment: BD Medical

Business: Medication Delivery Solutions (MDS)

Mandatory Location: Salt Lake City, Utah (4 days per week min) – relocation assistance provided.

Reporting: This VP role will report to the WW Vice President R&D, Medication Delivery Solutions (MDS), Tesh Elavia. 

Member of the MDS R&D Leadership Team

BD at a glance

BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety, and expand access to health care.

BD currently consists of three segments: BD Medical ($10.07B), BD Interventional ($4.98B) and BD Life Sciences ($5.19B)

• In Q1 2026 the BD Life Sciences segment will officially combine with Waters Corporation. BD will continue to operate under its existing segment structure while we also take actions to advance our New BD strategy and structure over time, which will be organized around four segments: BD Interventional, Connected Care, Medical Essentials and BioPharma Systems.

• BD’s Medical Segment and its respective AAD and PIVC platforms will join the soon to be created Medical Essentials Segment in FY 2026.

Key BD Facts (FY’24)

$20.2B Revenue

40B+ devices made annually

190+ countries served

$1B+ annual R&D investment and five global enterprise R&D centers of excellence

Our values: We do what is right; We thrive on innovation and demand quality; We are accountable; We learn and improve every day; We help each other be great.

BD Medical Segment

Our product areas serve as a bellwether on where the future of healthcare is going. Today’s top health trends are centered around the belief that care delivery should be simpler, safer, and more efficient – and we play a key role in addressing them. Across our three business units, our products are transforming medication preparation and administration, revolutionizing medication management through high-technology solutions and enabling the delivery of life-saving drugs to patients.

BD Medical represents the linchpin of BD’s storied 128-year history. The BD that we know today began in 1897 with a single syringe – starting a meaningful legacy of ushering in technical innovations that continuously improved medication delivery and management.

BD Medical’s three worldwide businesses (current BD):

Pharmaceutical Systems (PS): Enabling our customers’ success with high quality and innovative drug delivery solutions that improve patient quality of life around the world. 

Medication Management Solutions (MMS): Advancing medication management through automated, connected technologies across the full care continuum—aligning caregivers with patient needs and informing clinical care as patient conditions evolve.

Medication Delivery Solutions (MDS):